(Q53605296)

16 May 2018

title

Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA. (English)

1 reference

16 May 2018

5

Jean Claude Reubi

1 reference

16 May 2018

Beatrice Waser

1

1 reference

16 May 2018

Véronique Eltschinger

series ordinal

2

1 reference

16 May 2018

Karen Linder

series ordinal

3

1 reference

16 May 2018

Adrian Nunn

series ordinal

4

1 reference

16 May 2018

publication date

15 August 2006

1 reference

16 May 2018

number of pages

6

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

16 May 2018

volume

34

1 reference

16 May 2018

issue

1

1 reference

16 May 2018

page(s)

95-100

1 reference

16 May 2018

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-006-0229-9

Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-006-0229-9

Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-006-0229-9

Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study.

21 January 2018

1 reference

12 December 2020

Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs

1 reference

12 December 2020

Yttrium-90-labelled somatostatin-analogue for cancer treatment

1 reference

12 December 2020

99mTc-bombesin detects prostate cancer and invasion of pelvic lymph nodes

1 reference

12 December 2020

Bombesin receptors in distinct tissue compartments of human pancreatic diseases

1 reference

12 December 2020

Localization and characterization of neuropeptide receptors in human colon

1 reference

12 December 2020

Localization of specific binding sites for bombesin in the canine gastrointestinal tract

1 reference

12 December 2020

Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors

1 reference

12 December 2020

Peptide receptors as molecular targets for cancer diagnosis and therapy

1 reference

12 December 2020

Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes

1 reference

12 December 2020

Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin

1 reference

12 December 2020

Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study

1 reference

12 December 2020

Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14)

1 reference

12 December 2020

177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.

1 reference

12 December 2020

Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.

1 reference

12 December 2020

10.1007/S00259-006-0229-9

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018